| Vanguard Australian Property Securities Index ETF (VAP) |
Financials |
$3,010 |
Final Distribution Announcement
|
2 Jul 2026 9:31AM |
$92.770 |
$92.640 |
fallen by
0.14%
|
|
| Vanguard Australian Fixed Interest Index ETF (VAF) |
Financials |
$3,780 |
Final Distribution Announcement
|
2 Jul 2026 9:31AM |
$45.500 |
$45.340 |
fallen by
0.35%
|
|
| Vanguard FTSE Asia Ex Japan Shares Index ETF (VAE) |
Financials |
$765 |
Final Distribution Announcement
|
2 Jul 2026 9:31AM |
$115.060 |
$109.820 |
fallen by
4.55%
|
|
| Vanguard Australian Corporate Fixed Interest Index ETF (VACF) |
Financials |
$721 |
Final Distribution Announcement
|
2 Jul 2026 9:31AM |
$51.030 |
$51.060 |
risen by
0.06%
|
|
| Vanguard S&P 500 US Shares Index (Hedged) ETF (V5AH) VANGUARD S&P 500 US SHARES INDEX (HEDGED) ETF |
Financials |
$26 |
Final Distribution Announcement
|
2 Jul 2026 9:31AM |
$54.540 |
$56.490 |
risen by
3.58%
|
|
| Vanguard S&P 500 US Shares Index ETF (V500) VANGUARD S&P 500 US SHARES INDEX ETF |
- |
$169 |
Final Distribution Announcement
|
2 Jul 2026 9:31AM |
$55.770 |
$56.410 |
risen by
1.15%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,209 |
Eleventh Supplementary Bidder's Statement
|
2 Jul 2026 9:27AM |
$5.100 |
$4.960 |
fallen by
2.75%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- The Eleventh Supplementary Bidder's Statement was issued by Diamond Infraco 1 Pty Ltd.
- The offer for Atlas Arteria securities is unconditional, best, and final at A$5.10 per security, closing on 7 July 2026.
- IFM Global Infrastructure Fund (IFM GIF) now holds over 57% of Atlas Arteria securities.
- IFM GIF objects to a US$100m payment to extinguish the OTPP Put Option by Atlas Arteria.
- IFM GIF intends to conduct a strategic and operational review of Atlas Arteria after the offer closes.
- The review will cover Atlas Arteria’s capital structure, operational performance, cost base, and approach to capital allocation.
- There is concern about the sustainability of future distribution levels by Atlas Arteria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$5,648 |
Notification regarding unquoted securities - AII
|
2 Jul 2026 9:27AM |
$23.600 |
$19.580 |
fallen by
17.03%
|
|
| Viking Mines Limited (VKA) ORDINARY FULLY PAID |
Materials |
$23 |
LINKA TAILS DAM SAMPLING SUPPORTS HIGH HISTORICAL RECOVERIES
|
2 Jul 2026 9:26AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
VKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Tailings sampling at the Linka Tungsten Project returned low residual tungsten grades.
- Historical processing was effective in recovering the majority of tungsten.
- The thickness-weighted average grade of the samples was 0.03% WO3.
- Maximum grade found was 0.15% WO3.
- Recent testwork produced a 56.9% WO3 concentrate at 76% recovery.
- Maiden RC drilling scheduled to commence in July 2026.
- Drill testing to focus on primary tungsten mineralization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| First Sentier Geared Australian Share Fund Complex ETF (LEVR) |
Financials |
$130 |
Distribution Announcement
|
2 Jul 2026 9:26AM |
$1.425 |
$1.565 |
risen by
9.82%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$7 |
Application for quotation of securities - IBX
|
2 Jul 2026 9:26AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
| Peter Warren Automotive Holdings Limited (PWR) ORDINARY FULLY PAID |
Consumer Discretionary |
$165 |
Update on Wakeling Automotive Acquisition
|
2 Jul 2026 9:25AM |
$0.970 |
$0.960 |
fallen by
1.03%
|
|
PWR - Price-sensitive ASX Announcement
Full Release
Key Points
- Peter Warren Automotive Holdings Limited provides an update on the proposed acquisition of Wakeling Automotive.
- The transaction is governed by a share purchase agreement and a business purchase agreement, which are interdependent and must complete simultaneously.
- The acquisition is subject to conditions including approvals from the Australian Competition and Consumer Commission (ACCC) and other third-party approvals.
- The original deadline for fulfilling these conditions, known as the 'Sunset Date,' was extended from 2 May 2026 to 2 July 2026.
- Discussions have been ongoing with Wakeling's vendors about ACCC strategies, including the withdrawal of the initial application and resubmission of a new application.
- Wakeling's vendors have agreed to withdraw the initial ACCC application but do not intend to extend the Sunset Date further.
- Peter Warren Automotive continues to work towards completing the transaction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Megaport Limited (MP1) ORDINARY FULLY PAID |
Information Technology |
$4,877 |
Successful Completion of Retail Entitlement Offer
|
2 Jul 2026 9:25AM |
$20.770 |
$20.660 |
fallen by
0.53%
|
|
| First Sentier Active Cash Fund Active ETF (FSCF) FIRST SENTIER ACTIVE CASH FUND ACTIVE ETF |
- |
$6 |
Distribution Announcement
|
2 Jul 2026 9:24AM |
$100.500 |
$100.400 |
fallen by
0.10%
|
|
| First Sentier EX-20 Australian Share Active ETF (XX20) |
Financials |
$121 |
Distribution Announcement
|
2 Jul 2026 9:24AM |
$1.270 |
$1.335 |
risen by
5.12%
|
|
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,209 |
Change in substantial holding - IFM
|
2 Jul 2026 9:23AM |
$5.100 |
$4.960 |
fallen by
2.75%
|
|
| The Koala Company Limited (KOA) ORDINARY FULLY PAID |
Consumer Discretionary |
$274 |
Application for quotation of securities - KOA
|
2 Jul 2026 9:23AM |
$3.080 |
$3.020 |
fallen by
1.95%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$367 |
Update - Notification of buy-back - RG8
|
2 Jul 2026 9:23AM |
$2.690 |
$2.610 |
fallen by
2.97%
|
|
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
General Meeting Notice of Meeting, Access Letter & Proxy
|
2 Jul 2026 9:23AM |
$0.050 |
$0.056 |
risen by
12%
|
|
SCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Scalare Partners Holdings Limited is holding a General Meeting on 4 August 2026.
- The meeting will be held at Automic Group, Level 5, 126 Phillip Street, Sydney, NSW 2000.
- Voting can be done in person or by proxy, with detailed instructions provided for online, postal, and in-person submissions.
- Convertible notes and options play a significant role in the meeting's agenda, affecting share dilution and shareholder equity.
- Shareholder dilution scenarios are extensively covered, with tables depicting various outcomes based on different conversion and option exercise scenarios.
- Shareholders are encouraged to monitor announcements on the ASX platform and the company's website.
- Detailed terms of convertible notes and agreements are included in several annexures.
- An Independent Calculation Report by In.Corp Audit & Assurance Pty Ltd is annexed to the meeting notice.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ziller Global Fund Active ETF (ZILR) ZILLER GLOBAL FUND ACTIVE ETF |
Financials |
$12 |
Updated Product Disclosure Statement
|
2 Jul 2026 9:22AM |
$4.780 |
$4.300 |
fallen by
10.04%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$175,147 |
NEM Announces Second Quarter 2026 Earnings Conference Call
|
2 Jul 2026 9:22AM |
$131.980 |
$165.530 |
risen by
25.42%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$332 |
Positive DEP HER2-Lu preclinical data support Phase 1 entry
|
2 Jul 2026 9:22AM |
$0.710 |
$0.695 |
fallen by
2.11%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive preclinical data for DEP® HER2-Lu supports Phase 1 entry.
- Strong tumor uptake and low kidney accumulation observed.
- DEP® platform enhances radiopharmaceutical delivery.
- Statistically significant anti-tumor activity and survival benefit demonstrated.
- Phase 1 study planned for H2 CY2026 with FDA support.
- DEP® HER2-Lu targets HER2-positive cancers like gastric and gastro-oesophageal junction cancers.
- Potential to address unmet medical needs in HER2-positive cancer treatments.
- Investor webinar scheduled for 7 July 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$5,648 |
Sangdong Mine Transitions to Saleable Tungsten Production
|
2 Jul 2026 9:22AM |
$23.600 |
$19.580 |
fallen by
17.03%
|
|
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$20 |
Update on Progress at the Prodigy Gold Twin Bonanza Project
|
2 Jul 2026 9:21AM |
$0.064 |
$0.060 |
fallen by
6.25%
|
|
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$7 |
Garies REE Project - Significant Gallium Identified
|
2 Jul 2026 9:21AM |
$0.003 |
$0.003 |
fallen by
16.67%
|
|
MRQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant gallium identified at Garies REE Project.
- Drilling focused on magnetite-hosted REE mineralization.
- Gallium concentrations found in pyrite and monazite.
- Geochemical and geophysical methods used for analysis.
- Project part of MRG's strategy to exploit REE potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.